These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38829815)

  • 1. [Chronic hepatitis B in rheumatic diseases: issues of screening and reactivation of infection: A review].
    Gridneva GI; Belov BS; Aronova ES
    Ter Arkh; 2024 Jun; 96(5):523-530. PubMed ID: 38829815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B Reactivation in Rheumatic Diseases: Screening and Prevention.
    Koutsianas C; Thomas K; Vassilopoulos D
    Rheum Dis Clin North Am; 2017 Feb; 43(1):133-149. PubMed ID: 27890170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy--a report of long-term follow-up of serial cases and literature review.
    Xuan D; Yu Y; Shao L; Wang J; Zhang W; Zou H
    Clin Rheumatol; 2014 Apr; 33(4):577-86. PubMed ID: 24343455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral prophylaxis for preventing reactivation of hepatitis B virus in rheumatic patients: a systematic review and meta-analysis.
    Su J; Long L; Zou K
    Clin Rheumatol; 2018 Dec; 37(12):3201-3214. PubMed ID: 29637482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations.
    Mori S; Fujiyama S
    World J Gastroenterol; 2015 Sep; 21(36):10274-89. PubMed ID: 26420955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs.
    Lee YH; Bae SC; Song GG
    Int J Rheum Dis; 2013 Oct; 16(5):527-31. PubMed ID: 24164839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of psoriasis patients with hepatitis B or hepatitis C virus infection.
    Bonifati C; Lora V; Graceffa D; Nosotti L
    World J Gastroenterol; 2016 Jul; 22(28):6444-55. PubMed ID: 27605880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-tumor necrosis factor therapy.
    Lee YH; Bae SC; Song GG
    Clin Exp Rheumatol; 2013; 31(1):118-21. PubMed ID: 23111095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts.
    Tamori A; Koike T; Goto H; Wakitani S; Tada M; Morikawa H; Enomoto M; Inaba M; Nakatani T; Hino M; Kawada N
    J Gastroenterol; 2011 Apr; 46(4):556-64. PubMed ID: 21246383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of anti-HBc-positive patients with rheumatic diseases treated with disease-modifying antirheumatic drugs-a single-center analysis of 2054 patients.
    Schwaneck EC; Krone M; Kreissl-Kemmer S; Weißbrich B; Weiss J; Tony HP; Gadeholt O; Schmalzing M; Geier A
    Clin Rheumatol; 2018 Nov; 37(11):2963-2970. PubMed ID: 30238380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates on management strategies of hepatitis B virus reactivation in patients with resolved hepatitis virus B infection undergoing immunosuppressive therapy in rheumatology and the current situation in Niigata Rheumatic Center.
    Ito S
    Mod Rheumatol; 2021 Jul; 31(4):775-782. PubMed ID: 33021133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-rheumatic drug-induced hepatitis B virus reactivation and preventive strategies for hepatocellular carcinoma.
    Zhou Q; Zhang Q; Wang K; Huang T; Deng S; Wang Y; Cheng C
    Pharmacol Res; 2022 Apr; 178():106181. PubMed ID: 35301112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update.
    Hwang JP; Feld JJ; Hammond SP; Wang SH; Alston-Johnson DE; Cryer DR; Hershman DL; Loehrer AP; Sabichi AL; Symington BE; Terrault N; Wong ML; Somerfield MR; Artz AS
    J Clin Oncol; 2020 Nov; 38(31):3698-3715. PubMed ID: 32716741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies.
    Calabrese LH; Zein NN; Vassilopoulos D
    Ann Rheum Dis; 2006 Aug; 65(8):983-9. PubMed ID: 16627542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBV reactivation in rheumatic diseases patients under therapy: A meta-analysis.
    Moghoofei M; Mostafaei S; Ashraf-Ganjouei A; Kavosi H; Mahmoudi M
    Microb Pathog; 2018 Jan; 114():436-443. PubMed ID: 29223453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proposal for management of rheumatic disease patients with hepatitis B virus infection receiving immunosuppressive therapy.
    Harigai M; Mochida S; Mimura T; Koike T; Miyasaka N
    Mod Rheumatol; 2014 Jan; 24(1):1-7. PubMed ID: 24261752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reactivation of chronic hepatitis B].
    Šperl J
    Vnitr Lek; 2013 Jul; 59(7):591-6. PubMed ID: 23909265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection.
    Vassilopoulos D; Apostolopoulou A; Hadziyannis E; Papatheodoridis GV; Manolakopoulos S; Koskinas J; Manesis EK; Archimandritis AI
    Ann Rheum Dis; 2010 Jul; 69(7):1352-5. PubMed ID: 20472596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Tocilizumab-Containing Treatment.
    Kuo MH; Tseng CW; Lu MC; Tung CH; Tseng KC; Huang KY; Lee CH; Lai NS
    Dig Dis Sci; 2021 Nov; 66(11):4026-4034. PubMed ID: 33387124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.